Comment on: inhaled antimicrobial therapy--barriers to effective treatment, by J. Weers, inhaled antimicrobial therapy - barriers to effective treatment, Adv. Drug Deliv. Rev. (2015), http://dx.doi.org/10.1016/j.addr.2014.08.013.
Aradigm Corporation, 3929 Point Eden Way, Hayward, CA 94545, USA. Electronic address: cipollad@aradigm.com.
David
D
Cipolla
Aradigm Corporation, 3929 Point Eden Way, Hayward, CA 94545, USA.
Juergen
J
Froehlich
Aradigm Corporation, 3929 Point Eden Way, Hayward, CA 94545, USA.
Igor
I
Gonda
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D016503:Drug Delivery Systems / Q000379:methods*; D024901:Drug Resistance, Multiple, Bacterial; D006801:Humans; D012141:Respiratory Tract Infections / Q000188:drug therapy*
D000900:Anti-Bacterial Agents